36
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Effect of Resveratrol on MMP-2 Expression in Scleral Fibroblasts: An In Vitro Study

, , , &
Received 27 Sep 2023, Accepted 19 Apr 2024, Published online: 28 Apr 2024

References

  • Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, Wong TY, Naduvilath TJ, Resnikoff S. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036–1042. doi: 10.1016/j.ophtha.2016.01.006.
  • Harper AR, Summers JA. The dynamic sclera: extracellular matrix remodeling in normal ocular growth and myopia development. Exp Eye Res. 2015;133:100–111. doi: 10.1016/j.exer.2014.07.015.
  • Gentle A, Liu Y, Martin JE, Conti GL, McBrien NA. Collagen gene expression and the altered accumulation of scleral collagen during the development of high myopia. J Biol Chem. 2003;278(19):16587–16594. doi: 10.1074/jbc.M300970200.
  • Anuar NNM, Zulkafali NIN, Ugusman A. Modulation of matrix metalloproteinases by plant-derived products. Curr Cancer Drug Targets. 2021;21(2):91–106. doi: 10.2174/1568009620666201120144838.
  • Jia Y, Hu DN, Zhu D, Zhang L, Gu P, Fan X, Zhou J. MMP-2, MMP-3, TIMP-1, TIMP-2, and TIMP-3 protein levels in human aqueous humor: relationship with axial length. Invest Ophthalmol Vis Sci. 2014;55(6):3922–3928. doi: 10.1167/iovs.14-13983.
  • Zhao F, Zhou Q, Reinach PS, Yang J, Ma L, Wang X, Wen Y, Srinivasalu N, Qu J, Zhou X. Cause and effect relationship between changes in scleral matrix metallopeptidase-2 expression and myopia development in mice. Am J Pathol. 2018;188(8):1754–1767. doi: 10.1016/j.ajpath.2018.04.011.
  • Yuan J, Wu S, Wang Y, Pan S, Wang P, Cheng L. Inflammatory cytokines in highly myopic eyes. Sci Rep. 2019;9(1):3517. doi: 10.1038/s41598-019-39652-x.
  • Liu HH, Kenning MS, Jobling AI, McBrien NA, Gentle A. Reduced scleral TIMP-2 expression is associated with myopia development: TIMP-2 supplementation stabilizes scleral biomarkers of myopia and limits myopia development. Invest Ophthalmol Vis Sci. 2017;58(4):1971–1981. doi: 10.1167/iovs.16-21181.
  • Liu HH, Gentle A, Jobling AI, McBrien NA. Inhibition of matrix metalloproteinase activity in the chick sclera and its effect on myopia development. Invest Ophthalmol Vis Sci. 2010;51(6):2865–2871. doi: 10.1167/iovs.09-4322.
  • Avotri S, Eatman D, Russell-Randall K. Effects of resveratrol on inflammatory biomarkers in glaucomatous human trabecular meshwork cells. Nutrients. 2019;11(5):984. doi: 10.3390/nu11050984.
  • Ji K, Li Z, Lei Y, Xu W, Ouyang L, He T, Xing Y. Resveratrol attenuates retinal ganglion cell loss in a mouse model of retinal ischemia reperfusion injury via multiple pathways. Exp Eye Res. 2021;209:108683. doi: 10.1016/j.exer.2021.108683.
  • Huang FC, Kuo HC, Huang YH, Yu HR, Li SC, Kuo HC. Anti-inflammatory effect of resveratrol in human coronary arterial endothelial cells via induction of autophagy: implication for the treatment of Kawasaki disease. BMC Pharmacol Toxicol. 2017;18(1):3. doi: 10.1186/s40360-016-0109-2.
  • Zhang Y, Lu Y, Ong’achwa MJ, Ge L, Qian Y, Chen L, Hu X, Li F, Wei H, Zhang C, et al. Resveratrol inhibits the TGF-β1-induced proliferation of cardiac fibroblasts and collagen secretion by downregulating miR-17 in rat. Biomed Res Int. 2018;2018:8730593. doi: 10.1155/2018/8730593.
  • Raj P, Aloud BM, Louis XL, Yu L, Zieroth S, Netticadan T. Resveratrol is equipotent to perindopril in attenuating post-infarct cardiac remodeling and contractile dysfunction in rats. J Nutr Biochem. 2016;28:155–163. doi: 10.1016/j.jnutbio.2015.09.025.
  • Wildsoet CF, Chia A, Cho P, Guggenheim JA, Polling JR, Read S, Sankaridurg P, Saw S-M, Trier K, Walline JJ, et al. IMI – Interventions Myopia Institute: interventions for controlling myopia onset and progression report. Invest Ophthalmol Vis Sci. 2019;60(3):M106–M131. doi: 10.1167/iovs.18-25958.
  • Wu P-C, Chen C-T, Lin K-K, Sun C-C, Kuo C-N, Huang H-M, Poon Y-C, Yang M-L, Chen C-Y, Huang J-C, et al. Myopia prevention and outdoor light intensity in a school-based cluster randomized trial. Ophthalmology. 2018;125(8):1239–1250. doi: 10.1016/j.ophtha.2017.12.011.
  • Yam JC, Jiang Y, Tang SM, Law AKP, Chan JJ, Wong E, Ko ST, Young AL, Tham CC, Chen LJ, et al. Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control. Ophthalmology. 2019;126(1):113–124. doi: 10.1016/j.ophtha.2018.05.029.
  • Xu R, Zheng J, Liu L, Zhang W. Effects of inflammation on myopia: evidence and potential mechanisms. Front Immunol. 2023;14:1260592. doi: 10.3389/fimmu.2023.1260592.
  • Kim S-Y, Hassan AHE, Chung K-S, Kim S-Y, Han H-S, Lee H-H, Jung S-H, Lee K-Y, Shin J-S, Jang E, et al. Mosloflavone-resveratrol hybrid TMS-HDMF-5z exhibits potent in vitro and in vivo anti-inflammatory effects through NF-κB, AP-1, and JAK/STAT inactivation. Front Pharmacol. 2022;13:857789. and doi: 10.3389/fphar.2022.857789.
  • Yu Y, Li X, Mi J, Qu L, Yang D, Guo J, Qiu L. Resveratrol suppresses matrix metalloproteinase-2 activation induced by lipopolysaccharide in mouse osteoblasts via interactions with AMP-activated protein kinase and suppressor of cytokine signaling 1. Molecules. 2018;23(9):2327. doi: 10.3390/molecules23092327.
  • Pang Y, Qin M, Hu P, Ji K, Xiao R, Sun N, Pan X, Zhang X. Resveratrol protects retinal ganglion cells against ischemia induced damage by increasing Opa1 expression. Int J Mol Med. 2020;46(5):1707–1720. doi: 10.3892/ijmm.2020.4711.
  • Wei Q, Zhuang X, Fan J, Jiang R, Chang Q, Xu G, Yu Z. Proinflammatory and angiogenesis-related cytokines in vitreous samples of highly myopic patients. Cytokine. 2021;137:155308. doi: 10.1016/j.cyto.2020.155308.
  • Ohno-Matsui K, Jonas JB. Posterior staphyloma in pathologic myopia. Prog Retin Eye Res. 2019;70:99–109. doi: 10.1016/j.preteyeres.2018.12.001.
  • Meng T, Xiao D, Muhammed A, Deng J, Chen L, He J. Anti-inflammatory action and mechanisms of Resveratrol. Molecules. 2021;26(1):229. doi: 10.3390/molecules26010229.
  • Kodarahmian M, Amidi F, Moini A, Kashani L, Shabani Nashtaei M, Pazhohan A, Bahramrezai M, Berenjian S, Sobhani A. The modulating effects of Resveratrol on the expression of MMP-2 and MMP-9 in endometriosis women: a randomized exploratory trial. Gynecol Endocrinol. 2019;35(8):719–726. doi: 10.1080/09513590.2019.1576612.
  • Sun Y, Zhou QM, Lu YY, Zhang H, Chen QL, Zhao M, Su SB. Resveratrol inhibits the migration and metastasis of MDA-MB-231 human breast cancer by reversing TGF-β1-induced epithelial-mesenchymal transition. Molecules. 2019;24(6):1131. doi: 10.3390/molecules24061131.
  • Josifovska N, Albert R, Nagymihály R, Lytvynchuk L, Moe MC, Kaarniranta K, Veréb ZJ, Petrovski G. Resveratrol as inducer of autophagy, pro-survival, and anti-inflammatory stimuli in cultured human RPE cells. Int J Mol Sci. 2020;21(3):813. doi: 10.3390/ijms21030813.
  • Wang S, Wang Z, Yang S, Yin T, Zhang Y, Qin Y, Weinreb RN, Sun X. Tissue distribution of trans-resveratrol and its metabolites after oral administration in human eyes. J Ophthalmol. 2017;2017:4052094. doi: 10.1155/2017/4052094.
  • Ma C, Wang Y, Dong L, Li M, Cai W. Anti-inflammatory effect of resveratrol through the suppression of NF-κB and JAK/STAT signaling pathways. Acta Biochim Biophys Sin. 2015;47(3):207–213. doi: 10.1093/abbs/gmu135.
  • Chen HY, Lin PH, Shih YH, Wang KL, Hong YH, Shieh TM, Huang TC, Hsia SM. Natural antioxidant resveratrol suppresses uterine fibroid cell growth and extracellular matrix formation in vitro and in vivo. Antioxidants. 2019;8(4):99. doi: 10.3390/antiox8040099.
  • Johnson DE, O’Keefe RA, Grandis JR. Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15(4):234–248. doi: 10.1038/nrclinonc.2018.8.
  • Fang X, Hong Y, Dai L, Qian Y, Zhu C, Wu B, Li S. CRH promotes human colon cancer cell proliferation via IL-6/JAK2/STAT3 signaling pathway and VEGF-induced tumor angiogenesis. Mol Carcinog. 2017;56(11):2434–2445. doi: 10.1002/mc.22691.
  • Luan HF, Zhao ZB, Zhao QH, Zhu P, Xiu MY, Ji Y. Hydrogen sulfide postconditioning protects isolated rat hearts against ischemia and reperfusion injury mediated by the JAK2/STAT3 survival pathway. Braz J Med Biol Res. 2012;45(10):898–905. doi: 10.1590/s0100-879x2012007500090.
  • Jiang T, Gu J, Chen W, Chang Q. Resveratrol inhibits high-glucose-induced inflammatory "metabolic memory" in human retinal vascular endothelial cells through SIRT1-dependent signaling. Can J Physiol Pharmacol. 2019;97(12):1141–1151. doi: 10.1139/cjpp-2019-0201.
  • Wu C, Ge J, Yang M, Yan Q, Wang Y, Yu H, Yang H, Zou J. Resveratrol protects human nucleus pulposus cells from degeneration by blocking IL-6/JAK/STAT3 pathway. Eur J Med Res. 2021;26(1):81. doi: 10.1186/s40001-021-00555-1.
  • Singh R, Letai A, Sarosiek K. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat Rev Mol Cell Biol. 2019;20(3):175–193. doi: 10.1038/s41580-018-0089-8.
  • Tait SW, Green DR. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol. 2010;11(9):621–632. doi: 10.1038/nrm2952.
  • Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol. 2008;9(3):231–241. doi: 10.1038/nrm2312.
  • Zong DD, Liu XM, Li JH, Ouyang RY, Long YJ, Chen P, Chen Y. Resveratrol attenuates cigarette smoke induced endothelial apoptosis by activating Notch1 signaling mediated autophagy. Respir Res. 2021;22(1):22. doi: 10.1186/s12931-021-01620-3.
  • Takayama K, Ishida K, Matsushita T, Fujita N, Hayashi S, Sasaki K, Tei K, Kubo S, Matsumoto T, Fujioka H, et al. SIRT1 regulation of apoptosis of human chondrocytes. Arthritis Rheum. 2009;60(9):2731–2740. doi: 10.1002/art.24864.
  • Świerkot J, Nowak B, Czarny A, Zaczyńska E, Sokolik R, Madej M, Korman L, Sebastian A, Wojtala P, Lubiński Ł, et al. The activity of JAK/STAT and NF-κB in patients with rheumatoid arthritis. adv Clin Exp Med. 2016;25(4):709–717. doi: 10.17219/acem/61034.
  • Zhu WT, Zeng XF, Yang H, Jia ML, Zhang W, Liu W, Liu SY. Resveratrol loaded by folate-modified liposomes inhibits osteosarcoma growth and lung metastasis via regulating JAK2/STAT3 pathway. Int J Nanomedicine. 2023;18:2677–2691. doi: 10.2147/ijn.S398046.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.